Thanks, iwasadiver, for the explanation and yes, I agree. I was concerned about what appears to be a caveat (re new endpoints --below) to what otherwise (and, as you explained) appears to be great news:
"These factors could result in regulatory authorities refusing to accept either of these endpoints, or the analysis of our data relating to either of these endpoints, as a basis for approval."